Funding for Disproportionate Share Hospitals (Medicaid DSH). Funding for Medicare graduate medical education (GME). Support of telehealth policies, including for audio-only telehealth services. H.R.7053/S.3792 - acute hospital care at home waiver flexibility. H.R.2617, The Consolidated Appropriations Act of 2023. H.R.1613, Drug Price Transparency in Medicaid Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. H.R.5378, Lower Costs, More Transparency Act; Medicare physician payment reductions. H.R.6545, Physician Fee Schedule Update and Improvements Act. S.3430, Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (provisions related to Medicare physician payment). H.R.2474, Strengthening Medicare for Patients and Providers Act. S.3450, Mental and Physical Health Care Comorbidities Act of 2023. Consolidated Appropriations Act, Fiscal Year 2024 - provisions to address Medicare physician fee schedule payment policies and access to physician services.
Sustainability of safety net health systems. Social determinants of health. Promoting coordinated care. Support of telehealth policies, including for audio-only telehealth services. 340B Protect Act, H.R.4390. H.R.3290, To amend Title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.1613, Drug Price Transparency in Medicaid Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3281, Transparent PRICE Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. Support for policies to enhance health care workforce programs. H.R.5378, Lower Costs, More Transparency Act. S.3548, Health Care Prices Revealed and Information to Consumers Explained Transparency Act. S.3450, Mental and Physical Health Care Comorbidities Act of 2023. Support for policies to enhance healthcare workforce programs.
Funding for the HUD HOME program; H.R.2617, the Consolidated Appropriations Act of 2023; and congressionally directed spending request in the HHS Appropriations bill for capital funding for behavioral health facility. Consolidated Appropriations Act, Fiscal Year 2024 - provisions to address Medicare physician fee schedule payment policies and access to physician services.
Support for policies to enhance healthcare workforce programs.
Duration: December 1, 2018
to
present
General Issues: Medicare/Medicaid , Health Issues , Budget/Appropriations , Education , Housing , Taxation/Internal Revenue Code , Homeland Security , Pharmacy
Spending: about $880,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2018: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Mark H. Rayder
LA, Rep. Tom Latham; LA, Rep. Rodney Frelinghuysen; District Rep., Rep. Dean Gallo.
Marilyn Yager
Deputy Assistant to the President, White House Office of Public Liaison.
Michael Park
Health Policy Counsel, Senate Finance Committee.
Y. Brian Lee
Legislative Intern, Rep. Doug Lamborn.
Jane Lucas
Special Assistant to the President, White House Office of Legislative Affairs; Principal Deputy Director, IOS-Office of Health Reform, HHS; Legislative Director, Sen. John Thune (R-SD). All lobbying activities conducted in compliance with EO 13770.
Emily A. Shaw
n/a
Mark Rayder
n/a
Timothy L. Cordova
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $50,000. The report was filed on April 22.
Original Filing: 301571938.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH). Funding for Medicare graduate medical education (GME). Support of telehealth policies, including for audio-only telehealth services. H.R.7053/S.3792 - acute hospital care at home waiver flexibility. H.R.2617, The Consolidated Appropriations Act of 2023. H.R.1613, Drug Price Transparency in Medicaid Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. H.R.5378, Lower Costs, More Transparency Act; Medicare physician payment reductions. H.R.6545, Physician Fee Schedule Update and Improvements Act. S.3430, Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (provisions related to Medicare physician payment). H.R.2474, Strengthening Medicare for Patients and Providers Act. S.3450, Mental and Physical Health Care Comorbidities Act of 2023. Consolidated Appropriations Act, Fiscal Year 2024 - provisions to address Medicare physician fee schedule payment policies and access to physician services.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Sustainability of safety net health systems. Social determinants of health. Promoting coordinated care. Support of telehealth policies, including for audio-only telehealth services. 340B Protect Act, H.R.4390. H.R.3290, To amend Title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.1613, Drug Price Transparency in Medicaid Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3281, Transparent PRICE Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. Support for policies to enhance health care workforce programs. H.R.5378, Lower Costs, More Transparency Act. S.3548, Health Care Prices Revealed and Information to Consumers Explained Transparency Act. S.3450, Mental and Physical Health Care Comorbidities Act of 2023. Support for policies to enhance healthcare workforce programs.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Funding for the HUD HOME program; H.R.2617, the Consolidated Appropriations Act of 2023; and congressionally directed spending request in the HHS Appropriations bill for capital funding for behavioral health facility. Consolidated Appropriations Act, Fiscal Year 2024 - provisions to address Medicare physician fee schedule payment policies and access to physician services.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Support for policies to enhance healthcare workforce programs.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
4th Quarter, 2023
In Q4, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $50,000. The report was filed on Jan. 22.
Original Filing: 301539502.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH). Funding for Medicare graduate medical education (GME). Support of telehealth policies, including for audio-only telehealth services. H.R.7053/S.3792 - acute hospital care at home waiver flexibility. H.R.2617, The Consolidated Appropriations Act of 2023. H.R.1613, Drug Price Transparency in Medicaid Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. H.R.5378, Lower Costs, More Transparency Act; Medicare physician payment reductions. H.R.6545, Physician Fee Schedule Update and Improvements Act. S.3430, Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (provisions related to Medicare physician payment). H.R.2474, Strengthening Medicare for Patients and Providers Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Sustainability of safety net health systems. Social determinants of health. Promoting coordinated care. Support of telehealth policies, including for audio-only telehealth services. 340B Protect Act, H.R.4390. H.R.3290, To amend Title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.1613, Drug Price Transparency in Medicaid Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3281, Transparent PRICE Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. Support for policies to enhance health care workforce programs. H.R.5378, Lower Costs, More Transparency Act. S.3548, Health Care Prices Revealed and Information to Consumers Explained Transparency Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Funding for the HUD HOME program; H.R.2617, the Consolidated Appropriations Act of 2023; and congressionally directed spending request in the HHS Appropriations bill for capital funding for behavioral health facility.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on Oct. 20, 2023.
Original Filing: 301516186.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH). Funding for Medicare graduate medical education (GME). Support of telehealth policies, including for audio-only telehealth services. H.R.7053/S.3792 - acute hospital care at home waiver flexibility. H.R.2617, The Consolidated Appropriations Act of 2023. H.R.1613, Drug Price Transparency in Medicaid Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Sustainability of safety net health systems. Social determinants of health. Promoting coordinated care. Support of telehealth policies, including for audio-only telehealth services. 340B Protect Act, H.R.4390. H.R.3290, To amend Title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R.1613, Drug Price Transparency in Medicaid Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. H.R.3281, Transparent PRICE Act. H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023. Support for policies to enhance health care workforce programs.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Funding for the HUD HOME program; H.R.2617, the Consolidated Appropriations Act of 2023; and congressionally directed spending request in the HHS Appropriations bill for capital funding for behavioral health facility.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $50,000. The report was filed on July 20, 2023.
Original Filing: 301491860.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); COVID-19 regulatory changes in general; H.R.266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-10 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; support of telehealth policies, including for audio-only telehealth services; H.R.7053/S.3792 - acute hospital care at home waiver flexibility; H.R. 2617, the Consolidated Appropriations Act of 2023; H.R.1613, Drug Price Transparency in Medicaid Act of 2023; H.R.2665, Supporting Safety Net Hospitals Act; H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Sustainability of safety net health systems; social determinants of health; promoting coordinated care; H.R.266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; support of telehealth policies, including for audio-only telehealth services; 340B Protect Act, H.R.4390; H.R.2617, the Consolidated Appropriations Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R.1613, Drug Price Transparency in Medicaid Act of 2023; H.R.2665, Supporting Safety Net Hospitals Act; H.R.3281, Transparent PRICE Act; H.R.3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Funding for the HUD HOME program; H.R.2617, the Consolidated Appropriations Act of 2023; and congressionally directed spending request in the HHS Appropriations bill for capital funding for behavioral health facility.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R.7990, Healthy Homes Act, concerning low-income housing tax credit reforms related to addressing social determinants of health; H.R.2617, the Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 7990, Healthy Homes Act, concerning low-income housing tax credit reforms related to addressing social determinants of health.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2023
In Q1, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on April 20, 2023.
Original Filing: 301462669.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R.266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; support for issues regarding recognition of uncompensated are costs and addressing social determinants of health in the Medicaid and Medicare populations; H.R.7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R.5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R.7053/S.3792 - acute hospital care at home waiver flexibility; policy proposals to address mental and physical/medical comorbidities of beneficiaries in the Medicare/Medicaid programs; H.R.1868/Pub. L. No. 117-7, To prevent across-the-board direct spending cuts, and for other purposes/Medicare sequester; in general - protecting access to physician services for Medicare beneficiaries per preventing reductions resulting from Medicare sequestration, Statutory PAYGO, and reduction in Medicare conversion factor for CY2023; H.R.2617, the Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Provider status for pharmacists; implementation of the No Surprises Act, P.L. 116-260; sustainability of safety net health systems; social determinants of health; promoting coordinated care; FCCs COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R.5376; within Inflation Reduction Act, P.L. 117-169, impact of pharmaceutical pricing policies on 340B drug discount program; S.3799, PREVENT Pandemics Act (social determinants of health provisions); policy proposals to address mental and physical/medical comorbidities of beneficiaries in the Medicare/Medicaid programs; H.R.2617, the Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Funding for senior housing development; H.R.2617, the Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R.7990, Healthy Homes Act, concerning low-income housing tax credit reforms related to addressing social determinants of health; H.R.2617, the Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 7990, Healthy Homes Act, concerning low-income housing tax credit reforms related to addressing social determinants of health.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2022
In Q4, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on Jan. 20, 2023.
Original Filing: 301442501.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R.266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; support for issues regarding recognition of uncompensated care costs and addressing social determinants of health in the Medicaid and Medicare populations; H.R.7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R.5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R.7053/S.3792 - acute hospital care at home waiver flexibility; policy proposals to address mental and physical/medical comorbidities of beneficiaries in the Medicare/Medicaid programs; H.R.1868/Pub. L. No. 117-7, To prevent across-the-board direct spending cuts, and for other purposes/Medicare sequester; in general - protecting access to physician services for Medicare beneficiaries per preventing reductions resulting from Medicare sequestration, Statutory PAYGO, and reduction in Medicare conversion factor for CY2023; H.R.2617, the Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Provider status for pharmacists; implementation of the No Surprises Act, P.L. 116-260; sustainability of safety net health systems; social determinants of health; promoting coordinated care; FCCs COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R.5376; within Inflation Reduction Act, P.L. 117-169, impact of pharmaceutical pricing policies on 340B drug discount program; S.3799, PREVENT Pandemics Act (social determinants of health provisions); policy proposals to address mental and physical/medical comorbidities of beneficiaries in the Medicare/Medicaid programs; H.R.2617, the Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Funding for senior housing development; H.R.2617, the Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R.7990, Healthy Homes Act, concerning low-income housing tax credit reforms related to addressing social determinants of health; H.R.2617, the Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 7990, Healthy Homes Act, concerning low-income housing tax credit reforms related to addressing social determinants of health.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2022
In Q3, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on Oct. 20, 2022.
Original Filing: 301419181.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; support for issues regarding recognition of uncompensated care costs and addressing social determinants of health in the Medicaid and Medicare populations; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R. 5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; policy proposals to address mental and physical/medical comorbidities of beneficiaries in the Medicare/Medicaid programs; H.R. 1868/Pub. L. No. 117-7, To prevent across-the-board direct spending cuts, and for other purposes/Medicare sequester; in general - protecting access to physician services for Medicare beneficiaries per preventing reductions resulting from Medicare sequestration, Statutory PAYGO, and reduction in Medicare conversion factor for CY2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Provider status for pharmacists; implementation of the No Surprises Act, P.L. 116-260; sustainability of safety net health systems; social determinants of health; promoting coordinated care; FCCs COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R. 5376; within Inflation Reduction Act, P.L. 117-169, impact of pharmaceutical pricing policies on 340B drug discount program; S. 3799, PREVENT Pandemics Act (social determinants of health provisions); policy proposals to address mental and physical/medical comorbidities of beneficiaries in the Medicare/Medicaid programs.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Funding for senior housing development.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 7990, Healthy Homes Act, concerning low-income housing tax credit reforms related to addressing social determinants of health.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Housing Taxation/Internal Revenue Code
2nd Quarter, 2022
In Q2, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on July 20, 2022.
Original Filing: 301394478.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-19 PHE; support for issues regarding recognition of uncompensated care costs and addressing social determinants of health in the Medicaid and Medicare populations; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R. 5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; policy proposals to address mental and physical/medical comorbidities of beneficiaries in the Medicare/Medicaid programs; H.R. 1868/Pub. L. No. 117-7, To prevent across-the-board direct spending cuts, and for other purposes/Medicare sequester.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (FFCRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCCs COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R. 5376; within H.R.5376 impact of pharmaceutical pricing policies on 340B drug discount program; S. 3799, PREVENT Pandemics Act (social determinants of health provisions); policy proposals to address mental and physical/medical comorbidities of beneficiaries in the Medicare/Medicaid programs.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Funding for senior housing development.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 7990, Healthy Homes Act, concerning low-income housing tax credit reforms related to addressing social determinants of health.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Housing Taxation/Internal Revenue Code
1st Quarter, 2022
In Q1, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on April 20, 2022.
Original Filing: 301370828.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-19 PHE; support for issues regarding recognition of uncompensated care costs and addressing social determinants of health in the Medicaid and Medicare populations; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R. 5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (FFCRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCCs COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R. 5376; within H.R.5376 impact of pharmaceutical pricing policies on 340B drug discount program; S. 3799, PREVENT Pandemics Act (social determinants of health provisions).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021 - funding for the National Special Pathogen System, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - collection of data on high Medicaid Hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2021
In Q4, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on Jan. 20, 2022.
Original Filing: 301336090.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-19 PHE; support for issues regarding recognition of uncompensated care costs and addressing social determinants of health in the Medicaid and Medicare populations; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R. 5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (FFCRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCCs COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R. 5376; within H.R.5376 impact of pharmaceutical pricing policies on 340B drug discount program.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021 - funding for the National Special Pathogen System, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - collection of data on high Medicaid Hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on Oct. 20, 2021.
Original Filing: 301314193.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-19 PHE; support for issues regarding recognition of uncompensated care costs and addressing social determinants of health in the Medicaid and Medicare populations; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (FFCRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCCs COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R. 5376; within H.R.5376 impact of pharmaceutical pricing policies on 340B drug discount program.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021 - funding for the National Special Pathogen System, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - collection of data on high Medicaid Hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2021
In Q2, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on July 20, 2021.
Original Filing: 301290302.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; increase in FMAP funding per COVID-19 PHE; support for reforms to CMSs Accelerated Advanced Payment Program; H.R. 7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; American Rescue Plan, importance of 340B drug pricing program; Provider status for pharmacists; surprise medical billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021; the Families First Coronavirus Response Act (FFCRA); the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; and H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; and FCCs COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; The Consolidated Appropriations Act of 2021 - funding for the National Special Pathogen System, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - collection of data on high Medicaid Hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
In Q1, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on April 20, 2021.
Original Filing: 301266881.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Consolidated Appropriations Act of 2021, provisions regarding Medicaid (Division CC, Title II, Sections 201, 202, 203); the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; increase in FMAP funding per COVID-19 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; H.R. 1868/P.L. 117-7, To prevent across-the-board direct spending cuts, and for other purposes/Medicare sequester.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; Reductions and reforms to 340B program; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Consolidated Appropriations Act of 2021 - provisions regarding relief for health care providers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; issues concerning support of telehealth policies, including for audio-only telehealth services; H.R. 1319/P.L. 117-2, American Rescue Plan Act of 2021/regarding rescue funding for safety net hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
The Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - collection of data on high Medicaid hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2020
In Q4, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on Jan. 21, 2021.
Original Filing: 301244699.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; Medicaid Financing Accountability Rule (MFAR) proposed rule; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Consolidated Appropriations Act of 2021, provisions regarding Medicaid (Division CC, Title II, Sections 201, 202, 203); the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; increase in FMAP funding per COVID-19 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; H.R. 7292, The COVID-19 Hospital Forgiveness Act; issues concerning support of telehealth policies, including for audio-only telehealth services.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; Reductions and reforms to 340B program; Provider status for pharmacists; Surprise Medical Billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Consolidated Appropriations Act of 2021 - provisions regarding relief for health care providers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, Provider Relief Funds; H.R. 266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; issues concerning support of telehealth policies, including for audio-only telehealth services.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Consolidated Appropriations Act of 2021 - funding for the National Special Pathogen System, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - collection of data on high Medicaid hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2020
In Q3, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on Oct. 20, 2020.
Original Filing: 301222427.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; Medicaid Financing Accountability Rule (MFAR) proposed rule; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion; increase in FMAP funding per COVID-19 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 266/P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; H.R. 7292, The COVID-19 Hospital Forgiveness Act; issues concerning support of telehealth policies, including for audio-only telehealth services.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; Reductions and reforms to 340B program; Provider status for pharmacists; Surprise Medical Billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, preparedness during COVID-19 public health emergency; H.R. 266/P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; issues concerning support of telehealth policies, including for audio-only telehealth services.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Funding for Hospital Preparedness, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act - funding for the National Special Pathogen System, Hospital Preparedness Program, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - funding for Hospital Preparedness Program during COVID-19 public health emergency; collection of data on high Medicaid hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2020
In Q2, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on July 20, 2020.
Original Filing: 301200808.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; Medicaid Financing Accountability Rule (MFAR) proposed rule; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion; increase in FMAP funding per COVID-19 PHE; support for reforms to CMS's Accelerated Advanced Payment Program; H.R. 266/P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; H.R. 7292, The COVID-19 Hospital Forgiveness Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; Reductions and reforms to 340B program; Provider status for pharmacists; Surprise Medical Billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, preparedness during COVID-19 public health emergency; H.R. 266/P.L. 116-139, the Paycheck Protection Program and Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Funding for Hospital Preparedness, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act - funding for the National Special Pathogen System, Hospital Preparedness Program, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - funding for Hospital Preparedness Program during COVID-19 public health emergency; collection of data on high Medicaid hospitals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2020
In Q1, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on April 20, 2020.
Original Filing: 301179170.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; Medicaid Financing Accountability Rule (MFAR) proposed rule; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; Reductions and reforms to 340B program; Provider status for pharmacists; Surprise Medical Billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues regarding patient care, preparedness during COVID-19 public health emergency.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Funding for Hospital Preparedness, Ebola Preparedness and Response Activities; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act - funding for the National Special Pathogen System, Hospital Preparedness Program, Ebola Treatment Centers; the Families First Coronavirus Response Act (FFCRA); and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - funding for Hospital Preparedness Program during COVID-19 public health emergency.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2019
In Q4, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on Jan. 21, 2020.
Original Filing: 301127202.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; Reductions and reforms to 340B program; Provider status for pharmacists; Surprise Medical Billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Funding for Hospital Preparedness, Ebola Preparedness and Response Activities.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2019
In Q3, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on Oct. 21, 2019.
Original Filing: 301077472.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; Reductions and reforms to 340B program; Provider status for pharmacists; Surprise Medical Billing in general; sustainability of safety net health systems; social determinants of health; promoting coordinated care.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
2nd Quarter, 2019
In Q2, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on July 22, 2019.
Original Filing: 301058177.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
COPE Act of 2019, H.R. 1528; Reductions and reforms to 340B program; Provider status for pharmacists; Surprise Medical Billing in general; sustainability of safety net health systems.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
1st Quarter, 2019
In Q1, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $40,000. The report was filed on April 22, 2019.
Original Filing: 301038314.xml
Lobbying Issues
Funding for Disproportionate Share Hospitals (Medicaid DSH)
Funding for Medicare graduate medical education (GME)
Medicare site neutrality policies
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
H.R. 1528 - COPE Act of 2019
Reductions and reforms to 340B program
Provider status for pharmacists
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
4th Quarter, 2018
In Q4, ALSTON & BIRD LLP lobbied for The MetroHealth System , earning $10,000. The report was filed on Jan. 22, 2019.
Original Filing: 301016635.xml
Lobbying Issues
Issues related to S. 3763 - SAFE Hospitals Act of 2018.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2018
ALSTON & BIRD LLP filed a lobbying registration on Dec. 28, 2018 to represent The MetroHealth System, effective Dec. 1, 2018.
Original Filing: 301001726.xml
Issue(s) they said they’d lobby about: Medicare and Medicaid Disproportionate Share Hospital policies and reimbursement. Medicare HOPD policies and reimbursement. Department of Homeland Security Docket No. USCIS-2010-0012 re: Inadmissibility on Public Charge Grounds. 340B program reform. Healthcare reform. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate